PhRMA Comments to NIST’s Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.